BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17898269)

  • 1. The role of substance P in the pathogenesis of pterygia.
    Chui J; Di Girolamo N; Coroneo MT; Wakefield D
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4482-9. PubMed ID: 17898269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells.
    Di Girolamo N; Kumar RK; Coroneo MT; Wakefield D
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3430-7. PubMed ID: 12407153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P receptor expression in human skin keratinocytes and fibroblasts.
    Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
    Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea.
    Nishida T; Nakamura M; Ofuji K; Reid TW; Mannis MJ; Murphy CJ
    J Cell Physiol; 1996 Oct; 169(1):159-66. PubMed ID: 8841432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head.
    Di Girolamo N; Wakefield D; Coroneo MT
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4142-9. PubMed ID: 11095607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of p53 tumor suppressor gene in pterygia.
    Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
    Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What a study of pterygia teaches us about the cornea? Molecular mechanisms of formation.
    Reid TW; Dushku N
    Eye Contact Lens; 2010 Sep; 36(5):290-5. PubMed ID: 20724855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P regulates PTH secretion through the neurokinin-1 receptor.
    Galvin RJ; Babbey LE; Hipskind PA; Lamar T; George CA; Baez M; Gitter BD
    Biochem Biophys Res Commun; 2000 Apr; 270(1):230-4. PubMed ID: 10733932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of erythropoietin receptor in human pterygial tissues.
    Kase S; Osaki M; Jin XH; Ohgami K; Yoshida K; Saito W; Takahashi S; Nakanishi K; Ito H; Ohno S
    Int J Mol Med; 2007 Nov; 20(5):699-702. PubMed ID: 17912463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.
    Mauro J; Foster CS
    Semin Ophthalmol; 2009; 24(3):130-4. PubMed ID: 19437347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics.
    Peiretti E; Dessì S; Mulas MF; Abete C; Galantuomo MS; Fossarello M
    Exp Eye Res; 2006 Sep; 83(3):536-42. PubMed ID: 16696971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
    Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
    Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cetirizine hydrochloride on the expression of substance P receptor and cytokines production in human epidermal keratinocytes and dermal fibroblasts].
    Liu JY; Zhao YZ; Peng C; Li FQ; Zhu QG; Hu JH
    Yao Xue Xue Bao; 2008 Apr; 43(4):383-7. PubMed ID: 18664200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency.
    Kim KW; Park SH; Wee SW; Kim JC
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6355-62. PubMed ID: 23989187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis.
    Di Girolamo N; Coroneo MT; Wakefield D
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1963-8. PubMed ID: 11481258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6.
    Yamada N; Yanai R; Inui M; Nishida T
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):833-9. PubMed ID: 15728538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of periostin and interleukin-4 in recurrence of pterygia.
    Kuo CH; Miyazaki D; Yakura K; Araki-Sasaki K; Inoue Y
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):139-43. PubMed ID: 19661231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate.
    Gumus K; Karakucuk S; Mirza GE; Akgun H; Arda H; Oner AO
    Br J Ophthalmol; 2014 Jun; 98(6):796-800. PubMed ID: 23376569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.